[Experiences in the paraimmunization of cats in veterinary practice]. / Erfahrungen mit der Paramunisierung in der Katzenpraxis.

The inducer PIND-AVI was used prophylactically and therapeutically to test the effects of paramunization in a SPF cat colony and in various small animal practices. Prophylactic paramunization significantly improved the breeding results in the SPF cat colony. Mortality declined from 44.6% to 3.4%. The corresponding placebo groups were also tested thereby demonstrating the significance of the results. In comparison, the treatment of acutely diseased cats (all of the same litter or the same colony) showed that paramunization can also be used as an additional measure to the conventional therapy of infectious diseases with different etiology. Furthermore, it is possible that this measure alone can limit the incidence of disease providing the dosage is high enough and treatment is long enough (at least 3-5 days). The course of disease is thereafter mild and complications can be hindered. Chronic and recurrent infections (e.g., dermatitis and gingivitis) can be controlled with repeated paramunization. Prophylactic paramunization decreases the danger of an acute infection and provides for the newborn's fast adaptation to a contaminated environment. It also reduces the consequences of an exogenous and endogenous immune suppression.

[Therapy of herpes zoster through active premunization. 2. Treatment of zoster patients, results of experimental and clinical studies, treatment results]. / Therapie von Herpes Zoster durch aktive Prämunisierung. 2. Behandlung der Zoster--Patienten, Ergebnisse der experimentellen und klinischen Untersuchungen, Behandlungsergebnisse

A brief review of the previous and generally inadequate methods for the treatment of Herpes Zoster is presented. The concept of "active premunization" by appropriate inducer to provide an objective treatment is defined. A "Premunization Inducer" (PIND) based on a particular non-infectious preparation of an avian pox ("avipox") virus has been shown to enhance non-specific defence mechanisms in the host by T-cell stimulation and to inhibit virus proliferation by the induction of Interferon. The mode of action, efficacy against different viruses and the safety of the preparation is described and discussed. 114 patients with Herpes Zoster were treated with this "premunization Inducer" either orally (for buccal absorption) or by means of a nasal spray. There were no side effects and in all cases there was a marked reduction in the duration of the illness up to the shedding of the last scab (about 15 days instead of the more usual 31 days). Pain was relieved in some cases within 6 hours and in the remainder within 2 days: a rapid resolution of the inflammation could be observed. There were practically no signs of postherpetic neurological complications among the patients treated (the usual incidence of post-herpetic neuritis is around 18%). The treatment of Herpes I and Herpes II infection other viral conditions will be reported elsewhere.